Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea flag South Korea · Delayed Price · Currency is KRW
30,850
-2,300 (-6.94%)
Mar 9, 2026, 3:30 PM KST

Ildong Pharmaceutical Company Description

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea.

The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications.

It also provides raw material drugs; health foods and foods; beverages; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products.

The company was founded in 1941 and is headquartered in Seoul, South Korea.

Ildong Pharmaceutical Co., Ltd.
Country South Korea
Founded 1941
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,061
CEO Yun Paul Woongsup

Contact Details

Address:
2, Baumoe-ro 27-gil
Seoul, 137-130
South Korea
Phone 82 2 526 3114
Website ildong.com

Stock Details

Ticker Symbol 249420
Exchange Korea Stock Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency KRW
ISIN Number KR7249420001
SIC Code 2834

Key Executives

Name Position
Yun Paul Woongsup Chief Executive Officer